PAKRX Mutual Fund

PAKRX Mutual Fund

NAV$15.76
See how much of PAKRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$6M
Expense Ratio
0.77%
Dividend Yield (Current)
6.80%
Holdings
26
Inception Date
Aug 20, 2013
Fund Family
T.Rowe Price
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+4.90%
1 Year+7.16%
3 Year+10.89%
5 Year+4.65%
10 Year+7.56%

Asset Allocation

Stocks: 0.76%
Other: 99.24%
See how much of PAKRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
TRPZXT. Rowe Price Ltd Dur Infl Focus Bd Z16.61%
-T. Rowe Price New Income Z13.76%
-T. Rowe Price Value Z8.74%
-T. Rowe Price Growth Stock Z7.93%
TRMZXTrp International Bd (Usd Hedged) - Z5.22%
Top 10 Concentration: 71.82%Report Date: Jul 31, 2026
Download all 26 holdings for PAKRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.80%
Frequency
Annually
Latest Distribution
$0.55
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PAKRX Mutual Fund Overview

PAKRX Mutual Fund (T. Rowe Price Target 2030 Fund Adv Cl) is managed by T.Rowe Price with $6.3M in net assets. PAKRX expense ratio is 0.77%, holding 26 positions across various sectors. Inception date: 2013-08-20.

PAKRX performance shows a YTD return of 4.90%. The 1-year return is 7.16% and the 5-year return is 4.65%. PAKRX dividend yield stands at 6.80%, paid annually.

PAKRX top holdings include T. Rowe Price Ltd Dur Infl Focus Bd Z (16.6%), T. Rowe Price New Income Z (13.8%), T. Rowe Price Value Z (8.7%), T. Rowe Price Growth Stock Z (7.9%), Trp International Bd (Usd Hedged) - Z (5.2%). Go to all PAKRX holdings, PAKRX sectors, or PAKRX dividends.

PAKRX can be compared against other funds. Use PAKRX overlap to find shared positions, or PAKRX vs another fund for a side-by-side view. PAKRX alternatives are available via the screener, along with tax-loss harvesting opportunities.